Hasil Pencarian - David Sommerhalder
- Menampilkan 1 - 3 hasil dari 3
-
1
472 BDB001, a toll-like receptor 7 and 8 (TLR7/8) agonist, can be safely administered intravenously in combination with atezolizumab and shows clinical responses in advanced solid... oleh Alexander Chung, Omid Hamid, Manish Patel, Drew Rasco, Robert Andtbacka, Anthony Tolcher, Melissa Johnson, David Sommerhalder, Lixin Li
Diterbitkan 2021-11-01Artikel -
2
751 Monotherapy results from an ongoing phase 1a dose escalation study of NDI-101150, a highly selective oral hematopoietic progenitor kinase 1 (HPK1) inhibitor oleh Scott Daigle, Sunil Sharma, Xinyan Zhang, Martin Gutierrez, Patricia Fraser, David Sommerhalder, Scott Boiko, Esha A Gangolli, Bhaskar Srivastava, Frank G Basile, Marcus Noel, Amanda Hoerres, Nawaid Rana, Rama Balaraman
Diterbitkan 2023-11-01Artikel -
3
481 Phase 1/2 study of THOR-707 (SAR444245), a pegylated recombinant non-alpha IL-2, as monotherapy and in combination with pembrolizumab or cetuximab in patients (pts) with advanc... oleh Rui Wang, Judy Wang, Siqing Fu, Arun Azad, Gerald Falchook, Minal Barve, Hui Gan, Tarek Meniawy, Meredith McKean, Tira Tan, Giovanni Abbadessa, David Sommerhalder, Chen Chee, charlotte Lemeque, Nicole Acuff, Helene Pham, Jill Mooney, Neyssa Marina
Diterbitkan 2021-11-01Artikel